Results 221 to 230 of about 3,949,612 (252)

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

British Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa, Marianne Brodtkorb, Sämi Schär, Björn E. Wahlin, Micaela Hernberg, Michael Pedersen, Anastasios Stathis, Thilo Zander, Urban Novak, Thorsten Zenz, Natalie Fischer, Fatime Krasniqi, Felicitas Hitz, Ann‐Sofie Johansson, David Löfgren, Peter Albert Meyer, Anne Turid Bjørnevik, Giulio Sartori, Stefanie Hayoz, Andrea Fuhrer, Luzia Steiner, Francesco Bertoni, Luca Ceriani, Stefan Dirnhofer, Emanuele Zucca, Bjørn Østenstad   +25 more
wiley   +1 more source

Drug prescribing pattern in upper respiratory tract infections among the pediatric population attending outpatient clinics in pediatric hospitals. [PDF]

World J Clin Pediatr
Kamal AF, Abdelaziz EA, Fahim VF, Saad MH, Badr M.   +4 more
europepmc   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

British Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman, Christopher J. Black, Andrea Shin, Daniel Keszthelyi   +3 more
wiley   +1 more source

Antibiotic Usage for Treatment of Acute Upper Respiratory Tract Infections in Children in Lithuania from 2018 to 2022. [PDF]

Antibiotics (Basel)
Alčauskas T, Garuolienė K, Burokienė S.   +2 more
europepmc   +1 more source

Cofactors in Anaphylaxis: Insights From the European Anaphylaxis Registry

Clinical &Experimental Allergy, EarlyView.
Forty‐nine per cent of reactions reported suspected cofactors (26% of children/adolescents, 59% of adults). Adjusted odds ratios for reaction severity increased with increasing number of suspected cofactors. Consistent effects for individual suspected cofactors were only observed for acute infections (children) and alcohol (adults with food‐induced ...
Margitta Worm, Sabine Dölle‐Bierke, Guillaume Pouessel, Franziska Ruëff, Karin Hartmann, Claudia Pföhler, Maria Beatrice Bilò, Nicola Wagner, Nikolaos G. Papadopoulos, Lars Lange, Andrea Bauer, Johannes Trück, Paul J. Turner, Veronika Höfer   +13 more
wiley   +1 more source

Association Between Stimulant Medication Use in Attention-Deficit/Hyperactivity Disorder (ADHD) and the Increased Risk of Upper Respiratory Tract Infections: A Retrospective Study. [PDF]

Cureus
Dereschuk KJ, Chen PS, Espiridion ED.
europepmc   +1 more source

A prospective cluster randomized trial of an interventions bundle to reduce inappropriate antibiotic use for upper respiratory tract infections in the outpatient setting. [PDF]

BMC Infect Dis
Butt AA, Shams S, Jabeen A, Al-Nuaimi AA, Krishnan JI, Malik AB, Saleem S, Abdulaziz MH, Seyam NI, Aziz K, Kandil D, Thomas AG, Nafady-Hego H, Lone MI, Al Ajmi J, Bhutta ZA, AlSulaiti N, Hussein WES, Semaan S, Al-Abdulla SA, Al-Kuwari MG, Abou-Samra AB.   +21 more
europepmc   +1 more source

Eliciting parents' decision-making to antibiotic use for upper respiratory tract infections: A discrete choice experiment. [PDF]

J Glob Health
Duan L, Lin R, Wang D, Wang X, Zhang X, Ding L, Liu C.   +6 more
europepmc   +1 more source

The Assessment and Efficiency of Cefixime in Upper Respiratory Tract Infections: Insights and Perspectives. [PDF]

Cureus
Shafi MK, Shah AA, Khan MA, Faisal S, Iqbal S.   +4 more
europepmc   +1 more source

Epidemiology of Streptococcus pyogenes upper respiratory tract infections in Poland (2003-2017). [PDF]

J Appl Genet
Sitkiewicz I, Borek A, Gryko M, Karpińska A, Kozińska A, Obszańska K, Wilemska-Dziaduszycka J, Walory J, Bańska A, Belkiewicz K, Foryś M, Gołębiewska A, Hryniewicz W, Kadłubowski M, Kiedrowska M, Klarowicz A, Matynia B, Ronkiewicz P, Szczypa K, Waśko I, Wawszczak M, Wróbel-Pawelczyk I, Zieniuk B.   +22 more
europepmc   +1 more source